Trial Profile
Phase Ia trial of ORMD 0802 in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Feb 2009
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- Sponsors Oramed Pharmaceuticals
- 04 Feb 2009 Status changed from not yet recruiting to completed, as reported in an Oramed media release.
- 29 Oct 2008 New trial record.
- 23 Oct 2008 Approval received from the South Africa Medicines Control Council to begin testing of newly developed insulin suppository in volunteers, according to an Oramed Pharmaceuticals media release.